Primavera Capital Group
Primavera Capital Group is a china-based investment firm, focusing on private equity and special situations opportunities.
Business Model:
Revenue: $185.4M
Employees: 51-200
Rankings
Industries / Tags:
Detailed Primavera Capital Group Information
Geographic Data
Address: No.1 Jian Guo Men Wai Avenue
City: Beijing
State: beijing municipality
Zip: 100004
Country: CN
Financial Info
Stage:
Raised Last:
$0
Raised Total:$5B
Social
Linkedin
Crunchbase
Metrics
0Website Global Rank
0Website Monthly Traffic
Twitter Followers
Description
Primavera Capital Group is a China-based global investment firm. With offices located in Beijing and Hong Kong, Primavera manages both RMB and USD funds for leading institutions, corporations, and families in China and around the world. Primavera Capital Group was founded by Dr. Fred Hu, a renowned economist and successful investor, and a former partner and Chairman of Greater China at Goldman Sachs Group. The firm currently has 30+ investment professionals with an outstanding track record. The team combines global capital market experience, deep industry knowledge, and a unique network of relationships with policy-makers and regulators as well as leading CEOs and entrepreneurs in the region and globally. Primavera Capital Group puts great emphasis on rigorous fundamental research. The firm undertakes sophisticated analysis on economies, industries and companies to generate investment ideas, identify attractive opportunities, and guide its investment decisions. Primavera Capital Group employs a flexible investment strategy of growth capital, buy-out and control, and special situations - restructuring, distressed, and turn-arounds, etc.
Contact Phone:
Contact Email:
Primavera Capital Group went public on 1/22/2021 on the NYSE
Listed Exchange:
NYSE
IPO Date:
1/22/2021
Ticker Symbol:
PV.U
Live
Opened: -/share
| EBITDA | - |
| Total Cash | - |
| Total Debt | - |
| Total Revenue | - |
| Total Profit (Gross) | - |
| PE Ratio | - |
| Announced Date | Company | Transaction | Money Raised |
|---|---|---|---|
| 9/2021 | Accession Therapeutics Limited | Seed Round | - |
| 10/2019 | Danke Apartment | Series D | 190M |
| 6/2020 | Xingsheng Youxuan | Corporate Round | - |
| 3/2022 | Hex Trust | Series B | 0 |
| 8/2022 | Enflame | Series C | - |
| 4/2016 | Ant Group | Series B | 0 |
| 7/2017 | Dashu Finance | Series C | 118M |
| 3/2016 | Cainiao Logistics | Series A | 1.5B |
| 4/2019 | Onion Math | Series D | 44.7M |
| 1/2021 | 4Paradigm | Series D | 0 |
| 6/2022 | Project Twelve | Seed Round | 8M |
| 10/2021 | Ruigu | Series D | 250M |
| 5/2021 | Analytical Biosciences | Series A | - |
| 2/2019 | Danke Apartment | Series C | 500M |
| 9/2012 | Alibaba Group | Private Equity Round | 0 |
| 12/2021 | Xbiome | Series B | 0 |
| 1/2021 | Enflame | Series C | 278.8M |
| 12/2021 | SyMap Medical | Series E | 100M |
| 5/2018 | Souche | Series F | 578M |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 11/2022 | Subtle Medical | Series B | 25M |
| 5/2022 | Trash Warrior | Series A | 0 |
| 5/2021 | Jenscare Biotech | Venture Round | - |
| 11/2017 | WorldStrides | Private Equity Round | - |
| 2/2022 | Hong Kong Asia Heart Centre | Series D | 0 |
| 8/2019 | Ubox | Corporate Round | 225.5M |
| 11/2019 | LBX Pharmacy | Post-IPO Secondary | 557M |
| 1/2020 | Zap Surgical Systems | Private Equity Round | 0 |
| 12/2018 | Lu.com | Series C | 0 |
| 8/2022 | Pingxin Technology | Series A | - |
| 11/2020 | Deepinfar Ocean Technology | Series B | 0 |
| 8/2018 | Xpeng Motors | Series B | 584.5M |
| 11/2017 | Souche | Series E | 335M |
| 12/2018 | Hello TransTech | Series G | 581.5M |
| 5/2022 | Dimension | Seed Round | 8M |
| 11/2020 | Xbiome | Funding Round | - |
| 11/2019 | Shijiazhuang Junlebao Dairy | Funding Round | 569.1M |
| 3/2022 | Robotphoenix | Series D | 0 |
| 10/2021 | GoTo Group | Private Equity Round | 0 |
| 1/2022 | Starfield Food &a; Science Technology | Series B | 0 |
| 2/2021 | Xingsheng Youxuan | Series D | 0 |
| 6/2021 | Trash Warrior | Seed Round | 1.5M |
| 8/2021 | Shukun Technology | Series D | 105.8M |
| 10/2021 | Envision Group | Private Equity Round | 1B |
| 3/2012 | Xunlei | Series E | 50M |
| 10/2021 | Love, Bonito | Series C | 0 |
| 9/2016 | Yum! China | Private Equity Round | 460M |
| 1/2023 | Blackpanda | Series A | 15M |
| 11/2018 | Alibaba Bendi Shenghuo Fuwu Gongsi | Funding Round | 4B |
| 7/2018 | Zuoyebang | Series D | 350M |
| 11/2022 | Accession Therapeutics | Series A | 0 |
| 5/2021 | Beisen | Series F | 0 |
| 7/2017 | Moviebook | Series C | 73.8M |
| 12/2021 | Avistone Pharmaceuticals | Private Equity Round | 0 |
| 2/2022 | Adden Energy | Seed Round | 5.2M |
| 1/2017 | Koubei | Private Equity Round | 1.1B |
| 10/2018 | ByteDance | Equity | 3B |
| 7/2021 | OptoMedic | Series D | - |
| 8/2022 | Pingxin Technology | Series A | - |
| 6/2022 | Project Twelve | Seed Round | 0 |
| 5/2022 | Trash Warrior | Series A | 0 |
| 5/2022 | Starna Therapeutics | Series A | 0 |
| 3/2022 | Hex Trust | Series B | 0 |
| 3/2022 | Robotphoenix | Series D | 0 |
| 2/2022 | Hong Kong Asia Heart Centre | Series D | 0 |
| 1/2022 | Starfield Food &a; Science Technology | Series B | 0 |
| 12/2021 | Xbiome | Series B | 0 |
| 12/2021 | Avistone Pharmaceuticals | Private Equity Round | 0 |
Startup Industries
Startup Locations
Portfolio Current Status
Portfolio Employee Count
| Name | Price |
|---|
| Name | Size | Announced Date |
|---|
